Qing Li Peptide
Ipamorelin
Finnrick tested 3 samples of Ipamorelin (GHS antagonist) from Qing Li Peptide between 10 Jun 2025 and 21 Aug 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Qing Li Peptide
Ipamorelin
Tested 3 Samples
Last test 21 Aug 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Qing Li Peptide
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
21 Aug 2025
First
10 Jun 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 21 Aug 2025 | View | 10mg | 9.850mg | -1.5% | 99.67% | IP10/04-2025 | No Label / Silver Crimp / Clear Green Cap | Lab E | Public | |
| 24 Jul 2025 | View | 10mg | 18.500mg | +85.0% | 99.40% | (no batch ID) | White Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 10 Jun 2025 | View | 5mg | 4.420mg | -11.6% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |